Read the latest news from the MassBio community! This space is for members to share company updates and press releases. Members may not post stories that are copyrighted by news publications or post sales pitches.
Breakthroughs begin here. At the Inaugural Charles River World Congress on Animal Models in Drug Discovery & Development, industry leaders will convene to discuss reverse translational medicine. Read More
ColonaryConcepts has completed the sale of its proprietary colonoscopy preparation assets to a specialty pharmaceutical company specializing in gastrointestinal health Read More
Eisai, a leading global research and development-based pharma., and Charles River Laboratories, a leading early-stage contract research org., extend their two-year collaboration in integrated drug dis Read More
This course allows engineers in industry, hospital and academic settings to actually leverage that knowledge for better technological solutions for the health care system of the 21st century. Read More
CRL recently announced updates to its expanding oncology discovery business, including significant additions to its online Tumor Model Compendium. Read More
Ciraplex ULTRA Ultrasensitive Human 3-Plex IL-1β, IL-6, IL-10 Multiplexed Assay is a plate based protein array with ability to obtain low levels of detection for up to 3 biomarkers in one assay. Read More
Flexion Therapeutics announced that the U.S. FDA has accepted for filing the Company’s NDA for its lead investigational product candidate Zilretta (FX006). Read More